Victory Capital Management Inc Bausch & Lomb Corp Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$13.6 - $17.06 $6.93 Million - $8.69 Million	-509,408 Reduced 90.83%	51,423 $746,000
Q1 2024 May 03, 2024	SELL	$13.68 - $17.6 $164,693 - $211,886	-12,039 Reduced 2.1%	560,831 $9.7 Million
Q4 2023 Feb 05, 2024	SELL	$14.87 - $17.56 $173,235 - $204,573	-11,650 Reduced 1.99%	572,870 $9.77 Million
Q3 2023 Nov 06, 2023	SELL	$16.8 - $20.99 $6.79 Million - $8.48 Million	-404,085 Reduced 40.87%	584,520 $9.91 Million
Q2 2023 Jul 27, 2023	BUY	$16.03 - $20.07 $3.52 Million - $4.4 Million	219,292 Added 28.5%	988,605 $19.8 Million
Q1 2023 May 02, 2023	BUY	$15.67 - $18.91 $12.1 Million - $14.5 Million	769,313 New	769,313 $13.4 Million

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.3B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.